Leukapheresis cell concentration adjustment required for a successful recovery of HSC after cryopreservation.
Adult
Antigens, CD34
/ metabolism
Blood Platelets
/ cytology
Bone Marrow Transplantation
/ methods
Cell Count
Cell Survival
Cryopreservation
/ methods
Female
Hematopoietic Stem Cell Transplantation
/ methods
Hematopoietic Stem Cells
/ cytology
Humans
Leukapheresis
/ methods
Male
Middle Aged
Neutrophils
/ cytology
Transplantation, Autologous
Apheresis
Autologous transplantation
Stem cell
Viability test
Journal
Cryobiology
ISSN: 1090-2392
Titre abrégé: Cryobiology
Pays: Netherlands
ID NLM: 0006252
Informations de publication
Date de publication:
01 02 2020
01 02 2020
Historique:
received:
27
07
2019
revised:
26
09
2019
accepted:
26
09
2019
pubmed:
30
9
2019
medline:
21
10
2020
entrez:
30
9
2019
Statut:
ppublish
Résumé
The recovering of an adequate number of hematopoietic stem cells after cryopreservation is considered pivotal for successful transplantation. Various factors could influence the recovery of HSC following processing and cryopreservation. Therefore, leukapheresis product from thirty patients was cryopreserved in 10% DMSO in cryopreservation bags for their autologous bone marrow transplantation, and 2 ml were cryopreserved in cryovials for post-thaw viability assessment by flow cytometry. The percentage of viable HSCs recovered post-cryopreservation in leukapheresis product was significantly influenced by the concentration of the total nucleated cells cryopreserved per volume. Patients receiving a higher rate of viable HSCs resulted in earlier engraftment of both neutrophils and platelets, so they have been discharged earlier from the hospital. Furthermore, Storage temperature and duration played a role in the recovery of these cells and for the support of the findings, age of the patient at the time of collection did not show any impact on the recovery of this HSC post-cryopreservation. In conclusion, various influencing factors must be taken into consideration during the cryopreservation of HSCs, especially for poor mobilizing patients with a low number of collected hematopoietic stem cells.
Identifiants
pubmed: 31563591
pii: S0011-2240(19)30235-4
doi: 10.1016/j.cryobiol.2019.09.011
pii:
doi:
Substances chimiques
Antigens, CD34
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
21-25Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The Authors declare no conflict of interest.